Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Thumbnail
View/ Open

Show full item record
Author
Harrison, Douglas J.; Chi, Yueh-Yun; Tian, Jing; Hingorani, Pooja; Mascarenhas, Leo; McCowage, Geoffrey B.; Weigel, Brenda J.; Venkatramani, Rajkumar; Wolden, Suzanne L.; Yock, Torunn I.; Rodeberg, David A.; Hayes-Jordan, Andrea A.; Teot, Lisa A.; Spunt, Sheri L.; Meyer, William H.; Hawkins, Douglas S.; Shulki, Barry L.; Parisi, Marguerite T.
URI
http://hdl.handle.net/10342/10731
Subject
 chemotherapy; maximum standard uptake value (SUVmax); rhabdomyosarcoma 
Date
2021
Citation:
APA:
Harrison, Douglas J., & Chi, Yueh-Yun, & Tian, Jing, & Hingorani, Pooja, & Mascarenhas, Leo, & McCowage, Geoffrey B., & Weigel, Brenda J., & Venkatramani, Rajkumar, & Wolden, Suzanne L., & Yock, Torunn I., & Rodeberg, David A., & Hayes-Jordan, Andrea A., & Teot, Lisa A., & Spunt, Sheri L., & Meyer, William H., & Hawkins, Douglas S., & Shulki, Barry L., & Parisi, Marguerite T.. (January 2021). Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee. , (), - . Retrieved from http://hdl.handle.net/10342/10731

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Harrison, Douglas J., and Chi, Yueh-Yun, and Tian, Jing, and Hingorani, Pooja, and Mascarenhas, Leo, and McCowage, Geoffrey B., and Weigel, Brenda J., and Venkatramani, Rajkumar, and Wolden, Suzanne L., and Yock, Torunn I., and Rodeberg, David A., and Hayes-Jordan, Andrea A., and Teot, Lisa A., and Spunt, Sheri L., and Meyer, William H., and Hawkins, Douglas S., and Shulki, Barry L., and Parisi, Marguerite T.. "Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee". . . (), January 2021. February 02, 2023. http://hdl.handle.net/10342/10731.
Chicago:
Harrison, Douglas J. and Chi, Yueh-Yun and Tian, Jing and Hingorani, Pooja and Mascarenhas, Leo and McCowage, Geoffrey B. and Weigel, Brenda J. and Venkatramani, Rajkumar and Wolden, Suzanne L. and Yock, Torunn I. and Rodeberg, David A. and Hayes-Jordan, Andrea A. and Teot, Lisa A. and Spunt, Sheri L. and Meyer, William H. and Hawkins, Douglas S. and Shulki, Barry L. and Parisi, Marguerite T., "Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee," , no. (January 2021), http://hdl.handle.net/10342/10731 (accessed February 02, 2023).
AMA:
Harrison, Douglas J., Chi, Yueh-Yun, Tian, Jing, Hingorani, Pooja, Mascarenhas, Leo, McCowage, Geoffrey B., Weigel, Brenda J., Venkatramani, Rajkumar, Wolden, Suzanne L., Yock, Torunn I., Rodeberg, David A., Hayes-Jordan, Andrea A., Teot, Lisa A., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S., Shulki, Barry L., Parisi, Marguerite T.. Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee. . January 2021; (): . http://hdl.handle.net/10342/10731. Accessed February 02, 2023.
Collections